Not a Lexis Advance subscriber? Try it out for free.

Mealeys

Mealey's PI/Product Liability - Pennsylvania Jury Awards $1.75M In Risperdal Gynecomastia Case

PHILADELPHIA - A Pennsylvania state court jury on Nov. 9 awarded $1.75 million to a man who said his use of the atypical antipsychotic drug Risperdal from as young as 4 years old caused him to develop enlarged breasts in his adolescence (Nicholas Murray v. Janssen Pharmaceuticals, Inc., et al., No. 130401990, Pa. Comm. Pls., Philadelphia Co.).
Find full version on lexis Advance®